PER GLI SPECIALIZZANDI
Manda un abstract alla SIC:
per primi 100 sarà offerta
l’ospitalità gratuita al congresso
ISCRIVITI ALLA SIC
La Società Italiana di Cardiologia è un’ Associazione Scientifica Accademica tra le più antiche e prestigiose che vanta tra i suoi padri fondatori scienziati di chiara fama.
L’Associazione ha lo scopo di riunire i cultori della Cardiologia al fine di promuovere il progresso nel campo della conoscenza
Tavola rotonda “One Valve One Life – Le Nuove Frontiere della cardiologia mini-Invasiva”
Valve Prosthesis Beats Repair for 2-Year Durability in Severe Ischemic MR
ORLANDO, FL ( UPDATED WITH COMMENTARY ) — Two-year outcomes from the National Institutes of Health (NIH)–sponsored Cardiac Surgery Clinical Research Network (CTSN) trial suggest that patients with severe ischemic mitral regurgitation (MR) fare just as well when the valve is repaired or replaced, at least when it comes to measures of left ventricular reverse remodeling and survival, but that replacing the mitral valve provides a more durable correction of MR.
Association of Coffee Consumption with Total and Cause-Specific Mortality in Three Large Prospective Cohorts
Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011: Evidence for Stagnation in Young Adults, Especially Women
NOVITA' DA LONDRA 2015: LE NUOVE LINEE GUIDA SULLA PREVENZIONE DELLA MORTE IMPROVVISA
The new ESC Guidelines for the management of patients with ventricular arrhythmias (VA) and the prevention of sudden cardiac death (SCD), written by 18 Task Force members and supported by 810 references, are very broad and comprehensive. The document had 74 peer reviewers, and it was our privilege to act as review coordinators.
NOVITA' DA LONDRA 2015: LA LUNGHEZZA DEI TELOMERI DOPO RIVASCOLARIZZAZIONE
A short telomere length predicts adverse clinical outcomes following revascularisation procedures independent of age, according to a finalist abstract at the Cardiovascular Ageing and Senescence Young Investigator Award yesterday.
NOVITA' DA LONDRA 2015: LE NUOVE LINEE GUIDA SULL’IPERTENSIONE POLMONARE
The new 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension (PH) are authored by the Joint Task Force of the ESC and of the European Respiratory Society (ERS) and endorsed by the European Paediatric and Congenital Cardiology, the International Society for Heart and Lung Transplantation, the European League Against Rheumatism, and the European Society of Radiology.
NOVITA’ DA LONDRA 2015: LE NUOVE LINEE GUIDA SULL’INFARTO NSTEMI
The ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation represent an update of the 2011 version with several renewed recommendations based on evidence published over the past four years.
La FDA approva Repatha (evolocumad) per alcuni pazienti con alti livelli di colesterolo
The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.
Repatha, the second drug approved in a new class of drugs known as PCSK9inhibitors, is approved for use in addition to diet and maximally-tolerated statin therapy in adult patients with heterozygous familial hypercholesterolemia
Recommends Radial Over Femoral for Patients with Acute Coronary Syndrome (ACS)
August 29, 2015 -- London -- Today the European Society of Cardiology (ESC) gave the highest recommendation to the radial (wrist) approach for catheter-based interventions in patients with acute coronary syndromes (ACS). The "ACS without persistent ST-segment elevation (NSTE-ACS) guidelines," drafted by an international multidisciplinary Task Force, were introduced as part of this year's annual European Congress of Cardiology meeting, and are now published online.
VIVI CON IL CUORE
New Therapies in the Treatment of High Cholesterol: An Argument to Return to Goal-Based Lipid Guidelines
Specialty Society Clinical Practice Guidelines: Time for Evolution or Revolution?
Clinical Outcomes for Peripartum Cardiomyopathy in North America Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy)
New Insights and Clarity for Peripartum Heart Failure and Recovery in the Modern Era
Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Review of the Evidence
Comprehensive Cardiovascular Risk Factor Control Improves Survival The BARI 2D Trial
1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves
Severity of Metabolic Syndrome as a Predictor of Cardiovascular Disease Between Childhood and Adulthood
Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence
Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation
Catheter ablation is increasingly used to manage atrial fibrillation, but arrhythmia recurrences are common. Adenosine might identify pulmonary veins at risk of reconnection by unmasking dormant conduction, and thereby guide additional ablation to improve arrhythmia-free survival.
Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation
Cholesterol Lowering in 2015 Still Answering Questions About How and in Whom
Transformative Impact of Proteomics on Cardiovascular Health and Disease
Long-Term Outcome of Mustard/Senning Correction for Transposition of the Great Arteries (TGA) in Sweden and Denmark
Cerebral Microbleeds are Associated With an Increased Risk of Stroke: The Rotterdam Study
A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes
Risultati dello Studio presentato durante l'AHA Scientific Sessions 2014
Leggi l'articolo pubblicato sul nejm.org Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes